Kentley Insights’ 2025 Diseases of the Nervous System Global Market Size & Growth Report covers market size, revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with for ...

Parkinson's Disease Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7 major markets and provides an Excel-based forecast model for the Parkinson's Disease market through 2033. GlobalData estimated that the PD market was $3.4 billion across the 7MM in 2023. By the end of ...

The global neurodegenerative disease treatment market size reached USD 78.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 118.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.48% during 2025-2033. Neurodegenerative diseases refer to a group of brain disorders t ...

Report Scope The report provides an overview of the global anti-Parkinson’s drugs market and analyzes market trends. It includes global revenue ($ millions) for the base year data of 2024, estimated data for 2025 and forecast of compound annual growth rates (CAGRs) from 2025 to 2030. The market is s ...

This study covers the world outlook for neurological biomarkers for Alzheimers and Parkinsons diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars) ...

This study covers the world outlook for Parkinson's disease drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of ...

This study covers the world outlook for neurodegenerative diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is o ...

This study covers the world outlook for Parkinson's disease deep brain stimulation devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percen ...

This study covers the world outlook for neurodegenerative drugs for Parkinson's diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent ...

This study covers the world outlook for Parkinson's disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ...

This study covers the world outlook for Parkinson's disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the countr ...

This study covers the world outlook for neurodegenerative disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is ...

This study covers the world outlook for drugs for Alzheimer's and Parkinson's diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent sh ...

This study covers the world outlook for deep brain stimulation devices for Parkinson's diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ...

This study covers the world outlook for anti-Parkinson's drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of th ...

Parkinsons Disease (PD) Drugs Market 2025-2029 The parkinsons disease (PD) drugs market is forecasted to grow by USD 1771.8 mn during 2024-2029, accelerating at a CAGR of 5.7% during the forecast period. The report on the parkinsons disease (PD) drugs market provides a holistic analysis, market size ...

Global Parkinson’s Disease Drugs Market to Reach US$10.0 Billion by 2030 The global market for Parkinson’s Disease Drugs estimated at US$6.9 Billion in the year 2024, is expected to reach US$10.0 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Oral, one of the segments ...

Global Deep Brain Stimulation Devices Market to Reach US$2.9 Billion by 2030 The global market for Deep Brain Stimulation Devices estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Dual-Channel, one ...

Global Neurodegenerative Drugs Market to Reach US$64.9 Billion by 2030 The global market for Neurodegenerative Drugs estimated at US$43.7 Billion in the year 2024, is expected to reach US$64.9 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Dopamine Agonist, one of the ...

Global Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases Market to Reach US$16.4 Billion by 2030 The global market for Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases estimated at US$9.9 Billion in the year 2024, is expected to reach US$16.4 Billion by 2030, growing a ...

U.S. Neurorehabilitation Devices Market Size and Research The U.S. neurorehabilitation devices market size was exhibited at USD 699.51 million in 2023 and is projected to hit around USD 2,416.90 million by 2033, growing at a CAGR of 13.2% during the forecast period 2024 to 2033. U.S. Neurorehabilita ...

The global neuromodulation market size reached USD 8.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.8 Billion by 2033, exhibiting a growth rate (CAGR) of 9.2% during 2025-2033. The market is experiencing robust growth, driven by the increasing prevalence of chroni ...

Neurorehabilitation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on neurorehabilitation devices market which is experiencing strong growth. ...

Global Parkinson’s Disease Therapeutics Market Size - Industry Trends & Outlook The global Parkinson’s disease therapeutics market size reached US$ 5.92 Billion in 2024 and is expected to reach US$ 12.83 Billion by 2033, growing at a CAGR of 8.1% during the forecast period 2025-2033. The Parkinson’s ...

Neurological Biomarkers Market Growth & Trends The global neurological biomarkers market size is expected to reach USD 18.75 billion by 2030, expanding at a CAGR of 12.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increased funding for R&D of neurological biomarkers to ...